What do we know about the SARS-CoV-2 coronavirus in the environment?

被引：84
|
作者：
Nunez-Delgado, Avelino [1 ]
机构：
[1] Univ Santiago de Compostela, Engn Polytech Sch, Dept Soil Sci & Agr Chem, Campus Univ Lugo, Santiago De Compostela, Spain
来源：
SCIENCE OF THE TOTAL ENVIRONMENT | 2020年 / 727卷
关键词：
PERSISTENCE; VIRUSES; HEALTH; RISKS;
D O I：
10.1016/j.scitotenv.2020.138647
中图分类号：
X [环境科学、安全科学];
学科分类号：
08 ; 0830 ;
摘要：
In view of the current situation regarding the Covid-19 disease, a discussion is proposed on the need for research focusing on the presence and evolution of the SARS-CoV-2 virus in water, soils and other environmental compartments, reached through wastewater and sewage sludge spreading. Also, the evaluation of current treatments for wastewater and sewage sludge, as well as the eventual development of new specific techniques, based on sorption, nanotechnology, etc., would be of great interest for controlling the environmental dissemination of these viruses in the current and eventual future outbreaks. (C) 2020 Elsevier B.V. All rights reserved.
引用
收藏
页数：2
相关论文
共 50 条
  • [1] What do we know about the antibody responses to SARS-CoV-2?
    Alejandro Lagunas-Rangel, Francisco
    Chavez-Valencia, Venice
    IMMUNOBIOLOGY, 2021, 226 (02)
  • [2] What do we know about the function of SARS-CoV-2 proteins?
    Arevalo, Santiago Justo
    Castillo-Chavez, Adriana
    Calampa, Carmen Sofia Uribe
    Sifuentes, Daniela Zapata
    Huallpa, Cesar J.
    Bianchi, Gianfranco Landa
    Casas, Romina Garavito-Salini
    Aguilar, Mauro Quinones
    Chavarria, Roberto Pineda
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [3] What we know and what we need to know about the origin of SARS-CoV-2
    Domingo, Jose L.
    ENVIRONMENTAL RESEARCH, 2021, 200
  • [4] Virus interactions with the actin cytoskeleton—what we know and do not know about SARS-CoV-2
    Malgorzata Kloc
    Ahmed Uosef
    Jarek Wosik
    Jacek Z. Kubiak
    Rafik M. Ghobrial
    Archives of Virology, 2022, 167 : 737 - 749
  • [5] Indirect transmission of severe acute respiratory syndrome coronavirus virus 2 (SARS-CoV-2): What do we know and what do we not know?
    Ijaz, M. Khalid
    Nims, Raymond W.
    McKinney, Julie
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2022, 43 (05): : 676 - 678
  • [6] SARS-CoV-2 and the Brain: What Do We Know about the Causality of 'Cognitive COVID?
    Ali Awan, Hashir
    Najmuddin Diwan, Mufaddal
    Aamir, Alifiya
    Ali, Muneeza
    Di Giannantonio, Massimo
    Ullah, Irfan
    Shoib, Sheikh
    De Berardis, Domenico
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (15)
  • [7] Drugs against SARS-CoV-2: What do we know about their mode of action?
    Valle, Coralie
    Martin, Baptiste
    Touret, Franck
    Shannon, Ashleigh
    Canard, Bruno
    Guillemot, Jean-Claude
    Coutard, Bruno
    Decroly, Etienne
    REVIEWS IN MEDICAL VIROLOGY, 2020, 30 (06) : 1 - 10
  • [8] Hearing Loss in SARS-CoV-2: What Do We Know?
    Saniasiaya, Jeyasakthy
    ENT-EAR NOSE & THROAT JOURNAL, 2021, 100 (2_SUPPL) : 152S - 154S
  • [9] SARS-CoV-2: What do we know so far?
    Khedkar, Pratik H.
    Patzak, Andreas
    ACTA PHYSIOLOGICA, 2020, 229 (02)
  • [10] Cytokines and microRNAs in SARS-CoV-2: What do we know?
    Rarani, Fahimeh Zamani
    Rashidi, Bahman
    Abadi, Mohammad Hassan Jafari Najaf
    Hamblin, Michael R.
    Hashemian, Seyed Mohammad Reza
    Mirzaei, Hamed
    MOLECULAR THERAPY NUCLEIC ACIDS, 2022, 29 : 219 - 242
12345